Clover Health Investments vs HealthEquity
Clover Health Investments reported revenue of $1.9 billion in fiscal 2025, 1.5 times HealthEquity's $1.3 billion in fiscal 2026. Clover Health Investments' revenue grew 40.3% in its latest year, and HealthEquity's grew 9.5%. Clover Health Investments had an operating margin of -4.4%, against 24.6% at HealthEquity. Free cash flow was −$69 million at Clover Health Investments and $455 million at HealthEquity. Their fiscal years end in different months (December 31 and January 31), so the periods don't line up exactly.
Side by side
| Clover Health Investments | HealthEquity | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, Jan 31, 2026 |
| Revenue | $1.9B | $1.3B |
| Revenue growth | 40.3% | 9.5% |
| Revenue growth a year, last 5 years | 23.4% | 12.4% |
| Gross margin | — | 69.5% |
| Operating margin | −4.4% | 24.6% |
| Net margin | −4.5% | 16.4% |
| Free cash flow | −$69M | $455M |
| Free cash flow margin | −3.6% | 34.6% |
| Return on capital | −41.3% | 8.9% |
| Net debt to EBITDA | — | 1.3x |
| Dividends and buybacks | $18M | $299M |
| Change in diluted share count | 4.5% | −1.5% |
| Last close | $4.96 | $103.46 |
| P/E at the last close | — | 37.4× |
| Insider trades, last 12 months | sold $6.6 million | bought $11,942, sold $4.2 million |
| Piotroski F-score | 2 of 8 | 9 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Clover Health InvestmentsHealthEquity
Operating margin
Percent of revenue
Clover Health InvestmentsHealthEquity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Clover Health InvestmentsHealthEquity
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Clover Health Investments and HealthEquity pages.